Patents-Review.com
ClassID:

110992 ⎘

C12N2760/18562 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae; Pneumovirus, e.g. human respiratory syncytial virus; Methods of inactivation or attenuation by genetic engineering

Recent Application in this class:
#1
20250161436
2025-05-22

MULTIVALENT VACCINE FOR PARAMYXOVIRUSES AND USES THEREOF

 #2
20240417699
2024-12-19

ATTENUATION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS BY GENOME SCALE CODON-PAIR DEOPTIMIZATION

 #3
20240165217
2024-05-23

METHOD OF ELICITING AN IMMUNE RESPONSE AGAINST RESPIRATORY SYNCYTIAL VIRUS

 #4
20230302115
2023-09-28

Recombinant RSV with silent mutations, vaccines, and methods related thereto

 #5
20230293667
2023-09-21

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

 #6
20230293660
2023-09-21

Chimeric RSV, immunogenic compositions, and methods of use

 #7
20230270833
2023-08-31

Modulation of replicative fitness by deoptimization of synonymous codons

 #8
20220325252
2022-10-13

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

 #9
20220323568
2022-10-13

RSV vaccines and methods of production and use thereof

 #10
20210355169
2021-11-18

RECOMBINANT RSV LIVE VACCINE STRAIN AND PRODUCTION METHOD THEREFOR

 #11
20210100893
2021-04-08

Recombinant RSV with silent mutations, vaccines, and methods related thereto

 #12
20200397888
2020-12-24

RSV vaccines and methods of production and use thereof

 #13
20200283740
2020-09-10

Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

 #14
20200268865
2020-08-27

Modulation of replicative fitness by deoptimization of synonymous codons

 #15
20200030436
2020-01-30

Modified RSV F proteins and methods of their use

 #16
20190282690
2019-09-19

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

 #17
20190224306
2019-07-25

Recombinant RSV with silent mutations, vaccines, and methods related thereto

 #18
20190224300
2019-07-25

RSV vaccines and methods of production and use thereof

 #19
20190134187
2019-05-09

Modified RSV F proteins and methods of their use

 #20
20190040365
2019-02-07

Recombinant respiratory syncytial virus stains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

 #21
20180333477
2018-11-22

Chimeric RSV, immunogenic compositions, and methods of use

 #22
20180320146
2018-11-08

Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines

 #23
20180264098
2018-09-20

Modulation of replicative fitness by deoptimization of synonymous codons

 #24
20180208906
2018-07-26

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

 #25
20180207211
2018-07-26

Respiratory syncytial virus with a genomic deficiency complemented in trans

 #26
20180066238
2018-03-08

Live attenuated vaccines for pneumoviruses and related methods and materials

 #27
20170354727
2017-12-14

MODULATION OF REPLICATIVE FITNESS BY DEOPTIMIZATION OF SYNONYMOUS CODONS

 #28
20170189520
2017-07-06

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

 #29
20160228536
2016-08-11

RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) AND VACCINES

 #30
20160030549
2016-02-04

Recombinant RSV with silent mutations, vaccines, and methods related thereto

 #31
20150368622
2015-12-24

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

 #32
20150359872
2015-12-17

Modified RSV F proteins and methods of their use

 #33
20150329833
2015-11-19

Respiratory syncytial virus with a genomic deficiency complemented in trans

 #34
20150266930
2015-09-24

Modified RSV F proteins and methods of their use

 #35
20150265698
2015-09-24

Modified RSV F proteins and methods of their use

 #36
20150118732
2015-04-30

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

 #37
20150079117
2015-03-19

Paramyxovirus immunogens and related materials and methods

 #38
20140294879
2014-10-02

Modified RSV F proteins and methods of their use

 #39
20100291035
2010-11-18

Respiratory syncytial virus with a genomic deficiency complemented in trans

 #40
20100239617
2010-09-23

Modified RSV F proteins and methods of their use

 #41
20080118530
2008-05-22

Modulation of replicative fitness by deoptimization of synonymous codons

 #42
20070104734
2007-05-10

Recombinant viruses of the paramyxoviridae family with heterologous envelope glycoproteins

 #43
20060275774
2006-12-07

Negative strand RNA virus replicon

 #44
20060024797
2006-02-02

Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes

 #45
20060002958
2006-01-05

Attenuation of metapneumovirus